Ensifentrine is a medication with a novel mechanism of action for the maintenance treatment of chronic obstructive pulmonary disease.
cystic fibrosis
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis
The combination drug will help almost all cystic fibrosis patients.